Publications | Lund University Publications

1 – 3 of 3

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=author%3D%22Pavlova%2C+A.%22+or+(documentType+any+%22bookEditor+conferenceEditor%22+and+editor%3D%22Pavlova%2C+A.%22)&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

2013
Mark F8 haplotype and inhibitor risk: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort
Schwarz, J. ; Astermark, Jan ^LU ; Menius, E. D. ; Carrington, M. ; Donfield, S. M. ; Gomperts, E. D. ; Nelson, G. W. ; Oldenburg, J. ; Pavlova, A. and Shapiro, A. D. , et al. (2013) In Haemophilia 19(1). p.113-118
- Contribution to journal › Article
2009
Mark Impact of polymorphisms of the major histocompatibility complex class II, interleukin-10, tumor necrosis factor-alpha and cytotoxic T-lymphocyte antigen-4 genes on inhibitor development in severe hemophilia A
Pavlova, A. ; Delev, D. ; Lacroix-Desmazes, S. ; Schwaab, R. ; Mende, M. ; Fimmers, R. ; Astermark, Jan ^LU and Oldenburg, J. (2009) In Journal of Thrombosis and Haemostasis 7(12). p.2006-2015
- Contribution to journal › Article
2000
Mark Cystatin inhibition of cathepsin B requires dislocation of the proteinase occluding loop. Demonstration by release of loop anchoring through mutation of His110
Pavlova, A ; Mort, JS ; Abrahamson, Magnus ^LU and Bjork, I (2000) In FEBS Letters 487(2). p.156-156
- Contribution to journal › Article